Medibank Private Earnings Call Highlights Growth And Scale

Medibank Private Ltd. ((AU:MPL)) has held its Q2 earnings call. Read on for the main highlights of the call.

Medibank Private’s latest earnings call struck an overall upbeat tone, with management emphasizing solid earnings growth, strong momentum in its health services arm and the strategic step-up in primary care. Executives acknowledged cost and claims headwinds plus tougher competition, but stressed capital strength, rising dividends and reinvestment capacity as reasons to stay confident in the medium-term outlook.

Group earnings growth

Group operating profit climbed 6% to $381.7 million, underscoring resilient core performance despite softer investment returns and claims volatility. Underlying EPS, adjusted for investment returns, held broadly steady at $0.108 per share, signaling that profit expansion is being driven more by operating leverage than by markets.

Strong Medibank Health momentum

Medibank Health was the standout, with revenue up 27.5% and segment profit up 28.5% to $48.3 million as margins edged higher to 17.7%. The division delivered strong volume growth across community and acute services and wellbeing offerings, reinforcing management’s strategy to diversify beyond traditional health insurance.

Primary care scale and strategic M&A

The acquisition of Better Medical added 168 clinics and significant primary care scale, creating one of Australia’s largest primary care networks. Management framed the $163.5 million capital investment as a platform for both organic growth and further bolt-on deals, deepening Medibank’s role in the broader healthcare ecosystem.

Policyholder growth and brand momentum

Resident policyholder numbers rose 1.9% year-on-year, with Medibank up 0.8% and value brand ahm up 4.9% as competitive settings supported customer gains. Medibank’s growth accelerated to 0.9% over the last six months and its acquisition rate improved to 5.6%, more than offsetting modest pressure from customer lapses.

Customer value and engagement initiatives

The group highlighted $105 million in out-of-pocket savings for customers, including $3.3 million via its no-gap network and $23 million through Live Better rewards. Around 55% of Medibank resident customers interacted with health and wellbeing services, while Amplar Health’s 70,000 virtual interactions helped avoid an estimated 100,000 hospital bed days.

Dividend and capital strength

Shareholders are benefiting from the earnings trajectory, with an interim fully franked dividend of $0.083 per share, up 6.4% and representing a payout of roughly three-quarters of underlying profit. The capital position remains robust at 1.9 times PCA and a 13.8% capital ratio, above the 10–12% target range and leaving room for growth investment.

Nonresident performance

Nonresident gross profit increased 6.9% to $55.6 million and margins expanded by 80 basis points to 35.6%, helped by stronger worker segment profitability. Management is targeting further growth in both student and worker markets, using improved margin discipline to support returns despite cyclical swings in overseas demand.

Productivity and reduced one-off cyber costs

The company delivered $3 million of productivity savings in the half, a modest but important offset to rising cost pressures. One-off cyber-related expenses continued to trend lower, with management noting the major program is now largely embedded and future spend shifting toward business-as-usual security.

Higher operating expenses and reinvestment

Operating expenses rose 5.4% to $329.4 million and the expense ratio ticked up to 7.7%, reflecting inflation and higher volumes as well as stepped-up investment. Management is guiding to FY ’26 operating expenses of $690–695 million, with continued reinvestment partially cushioned by targeted cost-out and efficiency initiatives.

Revenue mix headwind and Live Better investment

Revenue growth is being held back by a shift toward lower-tier products and increased investment in the Live Better ecosystem, creating an estimated 150 basis point mix headwind similar to the second half of FY ’25. Revenue per policy unit growth fell by about 30 basis points, which weighs on headline revenue despite rising customer numbers.

Claims inflation and hospital utilization trends

Resident claims expense rose 4.9%, with claims per policy unit up 2.5% as extras claims jumped 310 basis points while hospital claims fell 120 basis points. Hospital utilization contracted by about 2.8%, roughly half of which management attributes to unwinding COVID-era tailwinds, complicating short-term claims forecasting.

Investment income pressure

Investment income declined by $19.6 million as lower central bank rates and weaker portfolio performance dragged on returns across both growth and defensive assets. Underlying net investment return eased 26 basis points to 2.74%, translating to about an $11 million reduction in underlying investment income and tempering overall profit growth.

Nonresident student volatility

Policy unit growth in the nonresident book was modest at 1.4%, with student policies contracting after unusually strong post-pandemic intakes and subsequent graduations. Elevated lapses in the student segment are creating near-term headwinds, though the worker portfolio remains a key avenue for profitable expansion.

Competitive pressure and aggregators

Management flagged rising cost-of-living stress and aggressive aggregator tactics as catalysts for increased switching and joining activity, particularly into lower cover products. This structural shift in consumer behavior is pressuring revenue per policy and could limit pricing power over time, forcing Medibank to compete harder on value and service.

Risk equalization timing benefit

Risk equalization contributed roughly a 50 basis point benefit to net claims growth in the period, cushioning the impact of underlying claims inflation. Executives cautioned that part of this benefit is timing related and may reverse in the second half, adding a layer of uncertainty to near-term claims outcomes and margins.

Acquisition funding and capital allocation

The Better Medical acquisition was funded from unallocated capital, trimming cash holdings and contributing to higher other income and expense items through M&A and integration costs. Even after this deployment, management maintains that the balance sheet can comfortably fund further growth initiatives while preserving its dividend profile.

Forward-looking guidance and outlook

For FY ’26, Medibank kept its guidance largely intact, expecting resident claims per policy unit growth of 2.6–2.9% and a smaller revenue-mix drag than in the first half. The group sees Medibank Health’s organic profit growing in line with the first half plus incremental Better Medical earnings, underpinned by solid capital, disciplined cost control and further productivity gains.

Medibank’s earnings call painted a picture of a business balancing near-term pressures with strategic progress in health services and primary care. For investors, the combination of steady profit growth, a higher dividend, strong capital and clear expansion plans suggests a company still on the front foot, even as claims trends, competition and revenue mix warrant close monitoring.